PL354331A1 - Pharmaceutical carrier formulation - Google Patents
Pharmaceutical carrier formulationInfo
- Publication number
- PL354331A1 PL354331A1 PL00354331A PL35433100A PL354331A1 PL 354331 A1 PL354331 A1 PL 354331A1 PL 00354331 A PL00354331 A PL 00354331A PL 35433100 A PL35433100 A PL 35433100A PL 354331 A1 PL354331 A1 PL 354331A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical carrier
- carrier formulation
- formulation
- pharmaceutical
- carrier
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40616499A | 1999-09-27 | 1999-09-27 | |
| PCT/US2000/026381 WO2001022942A1 (en) | 1999-09-27 | 2000-09-26 | Pharmaceutical carrier formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL354331A1 true PL354331A1 (en) | 2004-01-12 |
Family
ID=23606801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL00354331A PL354331A1 (en) | 1999-09-27 | 2000-09-26 | Pharmaceutical carrier formulation |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1216029A1 (xx) |
| JP (1) | JP2003510267A (xx) |
| KR (1) | KR20020064289A (xx) |
| CN (1) | CN1399542A (xx) |
| AR (1) | AR025867A1 (xx) |
| AU (1) | AU7716100A (xx) |
| BR (1) | BR0014308A (xx) |
| CA (1) | CA2388471A1 (xx) |
| CZ (1) | CZ20021082A3 (xx) |
| EA (1) | EA200200415A1 (xx) |
| HK (1) | HK1044485A1 (xx) |
| HU (1) | HUP0202652A3 (xx) |
| IL (1) | IL148543A0 (xx) |
| MX (1) | MXPA02003190A (xx) |
| NO (1) | NO20021476L (xx) |
| PL (1) | PL354331A1 (xx) |
| WO (1) | WO2001022942A1 (xx) |
| ZA (1) | ZA200203311B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7138393B2 (en) | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
| US20030105144A1 (en) * | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
| WO2004073692A1 (ja) * | 2003-02-18 | 2004-09-02 | Yamashita, Shinji | 難水溶性薬物のハードカプセル剤 |
| CN100342856C (zh) * | 2003-04-10 | 2007-10-17 | 上海医药工业研究院 | 达那唑半固体骨架制剂的组合物 |
| US8333989B2 (en) | 2005-10-26 | 2012-12-18 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system |
| CA2627351C (en) | 2005-10-26 | 2012-05-01 | Banner Pharmacaps, Inc. | Lipophilic vehicle-based dual controlled release matrix system |
| US20100093725A1 (en) * | 2006-10-31 | 2010-04-15 | Wyeth | Semi-solid formulations of phospholipase enzyme inhibitors |
| CN111032004B (zh) * | 2017-12-20 | 2023-10-20 | 弗门尼舍有限公司 | 口腔护理组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3636123A1 (de) * | 1986-10-23 | 1988-05-05 | Rentschler Arzneimittel | Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten |
| AU1911095A (en) * | 1994-02-18 | 1995-09-04 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
| EP1049459B1 (en) * | 1998-01-20 | 2009-04-22 | Applied Analytical Industries, Inc. | Oral liquid compositions |
-
2000
- 2000-09-26 CN CN00816307A patent/CN1399542A/zh active Pending
- 2000-09-26 AR ARP000105037A patent/AR025867A1/es unknown
- 2000-09-26 HU HU0202652A patent/HUP0202652A3/hu unknown
- 2000-09-26 CZ CZ20021082A patent/CZ20021082A3/cs unknown
- 2000-09-26 KR KR1020027003934A patent/KR20020064289A/ko not_active Application Discontinuation
- 2000-09-26 EA EA200200415A patent/EA200200415A1/ru unknown
- 2000-09-26 IL IL14854300A patent/IL148543A0/xx unknown
- 2000-09-26 JP JP2001526154A patent/JP2003510267A/ja active Pending
- 2000-09-26 MX MXPA02003190A patent/MXPA02003190A/es unknown
- 2000-09-26 AU AU77161/00A patent/AU7716100A/en not_active Abandoned
- 2000-09-26 EP EP00966880A patent/EP1216029A1/en not_active Withdrawn
- 2000-09-26 BR BR0014308-1A patent/BR0014308A/pt not_active Application Discontinuation
- 2000-09-26 PL PL00354331A patent/PL354331A1/xx not_active Application Discontinuation
- 2000-09-26 CA CA002388471A patent/CA2388471A1/en not_active Abandoned
- 2000-09-26 WO PCT/US2000/026381 patent/WO2001022942A1/en not_active Application Discontinuation
-
2002
- 2002-03-25 NO NO20021476A patent/NO20021476L/no not_active Application Discontinuation
- 2002-04-25 ZA ZA200203311A patent/ZA200203311B/xx unknown
- 2002-08-23 HK HK02106196.7A patent/HK1044485A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20021082A3 (cs) | 2002-06-12 |
| JP2003510267A (ja) | 2003-03-18 |
| HUP0202652A3 (en) | 2004-06-28 |
| NO20021476D0 (no) | 2002-03-25 |
| ZA200203311B (en) | 2003-12-31 |
| EP1216029A1 (en) | 2002-06-26 |
| NO20021476L (no) | 2002-04-16 |
| AR025867A1 (es) | 2002-12-18 |
| EA200200415A1 (ru) | 2002-10-31 |
| CN1399542A (zh) | 2003-02-26 |
| HUP0202652A2 (hu) | 2004-05-28 |
| IL148543A0 (en) | 2002-09-12 |
| AU7716100A (en) | 2001-04-30 |
| CA2388471A1 (en) | 2001-04-05 |
| HK1044485A1 (zh) | 2002-10-25 |
| WO2001022942A1 (en) | 2001-04-05 |
| KR20020064289A (ko) | 2002-08-07 |
| MXPA02003190A (es) | 2002-09-30 |
| BR0014308A (pt) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24226A (en) | Formulation | |
| GB9905898D0 (en) | Controlled-dose formulation | |
| GB9902304D0 (en) | Formulation | |
| HK1045102A1 (zh) | 藥物配方 | |
| IL148543A0 (en) | Pharmaceutical carrier formulation | |
| HRP20010951A2 (en) | Pharmaceutical complex | |
| GB9909154D0 (en) | Pharmaceutical formulation | |
| GB9927614D0 (en) | Sterliant formulation | |
| GB9926251D0 (en) | Pharmaceutical formulation | |
| GB9906126D0 (en) | Pharmaceutical formulations | |
| GB9930578D0 (en) | Pharmaceutical formulations | |
| GB9817470D0 (en) | Pharmaceutical formulation | |
| GB9802617D0 (en) | Pharmaceutical formulation | |
| GB9917775D0 (en) | Pharmaceutical formulation | |
| GB9910636D0 (en) | Pharmaceutical formulation | |
| GB9917772D0 (en) | Pharmaceutical formulation | |
| GB9922187D0 (en) | Pharmaceutical formulation | |
| GB9921396D0 (en) | Pharmaceutical formulation | |
| GB9917774D0 (en) | Pharmaceutical formulation | |
| GB9910633D0 (en) | Pharmaceutical formulation | |
| GB9927685D0 (en) | Pharmaceutical formulation | |
| GB9930700D0 (en) | Pharmaceutical formulation | |
| GB9919840D0 (en) | Pharmaceutical formulation | |
| GB9930878D0 (en) | Pharmaceutical formulation | |
| GB9917777D0 (en) | Pharmaceutical formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |